Clinical Trials Logo

Clinical Trial Summary

This study is planned for the cultural adaptation and validity of the "Virtual Reality Sickness Questionnaire".


Clinical Trial Description

Virtual reality (SG) creates a virtual environment that reflects a real environment and offers various experiences to users. Motion sickness can be observed in people after using virtual reality applications or simulation devices in education. There are questionnaires in the literature such as "Simulator Sickness Questionnaire" and "Motion Sickness Questionnaire". However, these questionnaires are specific surveys to evaluate symptoms that develop after vehicle handling or use of simulation devices for pilot training, while they are not ideal questionnaires to evaluate symptoms that may develop after virtual reality applications. Because there are important differences between virtual reality systems and simulation systems in terms of the appearance of motion disturbance symptoms. For this reason, "Virtual Reality Sickness Questionnaire" has been developed that can evaluate these symptoms. There is no Turkish version of the "Virtual Reality Sickness Questionnaire" in the literature. For this reason, this study is planned for the cultural adaptation and validity of the "Virtual Reality Sickness Questionnaire". ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04483999
Study type Observational
Source Hacettepe University
Contact
Status Completed
Phase
Start date June 30, 2021
Completion date March 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT03551184 - Inflammation and Brain Function - Main Study N/A
Completed NCT03551080 - Inflammation and Brain Function - Pilot Study N/A
Completed NCT05154019 - Managing Minds at Work: A Feasibility Pilot Trial N/A
Active, not recruiting NCT04565769 - Cognitive Function in Patients Treated for Metastatic Melanoma With Immune Checkpoint Inhibitors
Completed NCT02529592 - Endotoxin-induced Inflammatory and Behavioral Responses and Predictors of Individual Differences N/A
Recruiting NCT05697159 - 7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis